Fetal Medicine and the Pregnant Woman

In coming decades, fetal medicine may become a routine part of reproductive care. The measures pregnant women now take to protect fetal health are largely generic, like restricting their diets and using supplements. Relatively few interventions are based on specific conditions revealed by ultrasound...

Full description

Saved in:  
Bibliographic Details
Main Author: Wasserman, David (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Interlibrary Loan:Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany)
Published: 2018
In: The Hastings Center report
Year: 2018, Volume: 48, Issue: 2
Online Access: Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000naa a22000002c 4500
001 1937530558
003 DE-627
005 20251002055616.0
007 cr uuu---uuuuu
008 251002s2018 xx |||||o 00| ||eng c
024 7 |a 10.1002/hast.841  |2 doi 
035 |a (DE-627)1937530558 
035 |a (DE-599)KXP1937530558 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Wasserman, David  |e VerfasserIn  |4 aut 
245 1 0 |a Fetal Medicine and the Pregnant Woman 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a In coming decades, fetal medicine may become a routine part of reproductive care. The measures pregnant women now take to protect fetal health are largely generic, like restricting their diets and using supplements. Relatively few interventions are based on specific conditions revealed by ultrasound or genetic testing. A recent finding, though, may herald a dramatic rise in “personalized” fetal medicine: certain drugs already approved by the Food and Drug Administration can apparently boost neural growth in fetuses with Down syndrome, improving cognitive functioning in the future child. Many more condition-specific findings are likely in the near future. But as commentators have frequently observed about prenatal testing, technologies that appear to increase reproductive options also complicate and constrain them. 
773 0 8 |i Enthalten in  |a Hastings Center  |t The Hastings Center report  |d Malden, Mass. : Wiley, 1971  |g 48(2018), 2  |h Online-Ressource  |w (DE-627)341346551  |w (DE-600)2067369-3  |w (DE-576)258761822  |x 1552-146X  |7 nnas 
773 1 8 |g volume:48  |g year:2018  |g number:2 
856 4 0 |u https://doi.org/10.1002/hast.841  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/hast.841  |x Verlag  |z lizenzpflichtig  |3 Volltext 
912 |a NOMM 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4779656737 
LOK |0 003 DE-627 
LOK |0 004 1937530558 
LOK |0 005 20251002055616 
LOK |0 008 251002||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2025-09-26#4520A562881753A469462780CEE24FB44B10883C 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixrk  |a ixzs  |a zota  |a tiep 
ORI |a TA-MARC-ixtheoa001.raw